Author

E. Kankuri

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cell Biology· 1 Microbiology· 1 Pharmacology & Toxicology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 3 Organism:human· 2 Research Focus:drug response / drug discovery· 1 Research Focus:host-pathogen & immune response· 1 Organism:plant (other)· 1 Assay:proteomics· 1

Frequent Co-Authors

A. Harjula· 1 shared A. Nummi· 1 shared A. Vento· 1 shared D. Blokhina· 1 shared Erika Wilkman, Kari Teittinen, Mika Laine, Markku Kupari, Juha Sinisalo, Mat, Sari Kivistö· 1 shared H. Alapulli· 1 shared I. Ilves· 1 shared I. Teino· 1 shared

Activity by Year

2020-2023 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 12 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperCell Biology

A. Harjula

Mutual co-authors in cluster

Author profile →

3 papers

Recent·Most cited

Novel RNA m6A methyltransferase METTL16 inhibitors

S. Selberg, L. Ivanova, M. Kotli, K. Herodes, D. Blokhina, E. Kankuri, N. Seli, I. Ilves, I. Teino, M. Saarma, M. Karelson

This study identifies two nanomolar METTL16 inhibitors that reduce leukemia cell viability and m6A levels in HL-60 cells.

bioRxiv · Mar 27, 2023 · PreprintPharmacology & Toxicology

Epicardial transplantation of autologous atrial appendage micrografts-evaluation of safety and feasibility in pigs after coronary artery occlusion

A. Nummi, T. Pätilä, S. Mulari, M. Lampinen, T. Nieminen, M. I. Mäyränpää, A. Vento, A. Harjula, E. Kankuri, Erika Wilkman, Kari Teittinen, Mika Laine, Markku Kupari, Juha Sinisalo, Mat, Sari Kivistö

This study evaluates the safety and feasibility of epicardial transplantation of autologous atrial appendage micrografts in pigs after coronary artery occlusion, finding reduced inflammation compared to ECM patches.

bioRxiv · Oct 18, 2021Cell Biology

Dual-light photodynamic therapy administered daily provides a sustained antibacterial effect on biofilm and prevents Streptococcus mutans adaptation

S. Nikinmaa, H. Alapulli, P. Auvinen, M. Vaara, J. Rantala, E. Kankuri, T. Sorsa, J. Meurman, T. Patila

This study shows that dual-light photodynamic therapy (aPDT + aBL) prevents Streptococcus mutans biofilm adaptation and provides sustained antibacterial effects compared to single-light treatments.

PLOS ONE · May 6, 2020Peer-reviewedMicrobiology